Structure via PubChem · Public domain (PubChem)
clorotepine
Sign in to saveClorotepine (; brand names Clotepin, Clopiben), also known as octoclothepin or octoclothepine, is an antipsychotic of the tricyclic group which was derived from perathiepin in 1965 and marketed in the Czech Republic by Spofa in or around 1971 for the treatment of schizophrenic psychosis.
In the Vinony graph
Vinony's link graph records 1,799 inbound references to clorotepine, and connects out to propranolol, fluphenazine and zuclopenthixol.
It is catalogued under topics including 4-Methylpiperazin-1-yl compounds, Antipsychotics and Chemical pages without DrugBank identifier.
Vinony links it to 6 Wikipedia language editions.
Chemical data
- Formula
- C19H21ClN2S
- Molecular weight
- 344.9 g/mol
- IUPAC name
- 1-(3-chloro-5,6-dihydrobenzo[b][1]benzothiepin-5-yl)-4-methylpiperazine
- SMILES
- CN1CCN(CC1)C2CC3=CC=CC=C3SC4=C2C=C(C=C4)Cl
- InChIKey
- XRYLGRGAWQSVQW-UHFFFAOYSA-N
- XLogP
- 4.3
- Polar surface area
- 31.8 Ų
- H-bond donors
- 0
- H-bond acceptors
- 3
- Formal charge
- 0
via PubChem
Drug data · ChEMBL
- Max clinical phase
- Phase 2
- Molecule type
- Small molecule
via ChEMBL · EBI
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 344.111
Show 3 more facts
- chemical formula
- C₁₉H₂₁ClN₂S
- canonical SMILES
- CN1CCN(CC1)C2CC3=CC=CC=C3SC4=C2C=C(C=C4)Cl
- Commons category
- Clorotepine
Sources (2)
via Wikidata · CC0
~1 min read
Encyclopedic overview
2 sectionsContents
- See also
- References
Clorotepine (; brand names Clotepin, Clopiben), also known as octoclothepin or octoclothepine, is an antipsychotic of the tricyclic group which was derived from perathiepin in 1965 and marketed in the Czech Republic by Spofa in or around 1971 for the treatment of schizophrenic psychosis.
Clorotepine is known to have high affinity for the dopamine D1, D2, D3, and D4 receptors, the serotonin 5-HT2A, 5-HT2B, 5-HT2C, 5-HT6, and 5-HT7 receptors, the α1A-, α1B-, and α1D-adrenergic receptors, and the histamine H1 receptors, where it has been it has been confirmed to act as an antagonist (or inverse agonist) at most sites (and likely is as such at all of them based on structure–activity relationships), and it also blocks the reuptake of norepinephrine via inhibition of the norepinephrine transporter.
Excerpted from Wikipedia’s “clorotepine” article, available under the CC BY-SA 4.0 licence.